BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
DTSTART:20230312T030000
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:MDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20231105T010000
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:MST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20230519T002710Z
UID:15B6F1FE-B99A-42FF-A06C-A529146696CC
DTSTART;TZID=America/Denver:20230518T124500
DTEND;TZID=America/Denver:20230518T140000
DESCRIPTION:The Department of Biomedical Engineering at the University of A
 lberta is a joint effort between the Faculty of Engineering and the Facult
 y of Medicine and Dentistry. The University is also the host site for the 
 National Research Council’s National Institute of Nanotechnology. Togeth
 er these entities create a critical mass for research in nanomedicine.\n\n
 Nanomedicine involves drug delivery using nanopolymers and aerosols to pro
 mote bone and tissue regeneration and the development of improved diagnost
 ic tools including MEMS and NEMS. Wound healing and disease diagnosis are 
 areas of active research.\n\nSilver\, and specifically silver ions Ag+\, a
 re known to be beneficial in the treatment of wounds. In the mid 1990s\, n
 anotechnology provided an opportunity to develop a new silver delivery sys
 tem that released biologically active species other than Ag+. Nanocrystall
 ine silver releases multiple species species into solution which have diff
 erent biological properties than Ag+. In vitro\, in vivo and clinical stud
 ies have clearly demonstrated that this new form of silver has unique anti
 -inflammatory and anti microbial properties.\n\nNanotechnology can not onl
 y change the chemical properties of a material but also its optical proper
 ties. Current work using these modified optical properties is aimed at poi
 nt of care diagnostics which require no amplification and can be read by e
 ye. Such developments would make it possible to see molecules as small as 
 2nm on a surface.\n\nThe speaker will discuss the use of nanotechnology in
  the treatment of current medical problems.\n\nSpeaker Dr Robert E. Burrel
 l\, AOE\, CSM\, PhD\, FCAHS\, FNAIDr.\n\nDr Burrell\, is the Sorensen Chai
 r in Commercialization of Biomedical Technology and a Professor of Chemica
 l and Materials Engineering in the Faculty of Engineering as well as Profe
 ssor and Chair of Biomedical Engineering in the Faculties of Engineering a
 nd Medicine &amp; Dentistry at the University of Alberta. He is a former two t
 erm Canada Research Chair in Nanostructured Biomaterials. He has been reco
 gnized worldwide for his work in wound care. He is a named inventor on &gt;30
 0 patents and patent applications worldwide including those for Acticoat d
 ressings\, the world’s first therapeutic application of nanotechnology. 
 In Canada\, he has won the two highest awards for Innovation – the Gover
 nor General’s Innovation Award and Principal Award from the Manning Foun
 dation. He has also received the Meritorious Service Cross\, is a fellow o
 f The Canadian Academy of Health Sciences and has won the Jonas Salk Award
 \, the ASM International - ASM Engineering Materials Achievement Award\, W
 orld Union of Wound Healing Society Lifetime Achievement Award\, Fellow of
  the National Academy of Inventors and a member of the Alberta Order of Ex
 cellence.\n\nCo-sponsored by: CSSE Edmonton Branch\n\nVirtual: https://eve
 nts.vtools.ieee.org/m/361294
LOCATION:Virtual: https://events.vtools.ieee.org/m/361294
ORGANIZER:stonyjones@ieee.org
SEQUENCE:12
SUMMARY:Nanomedicine in Alberta
URL;VALUE=URI:https://events.vtools.ieee.org/m/361294
X-ALT-DESC:Description: &lt;br /&gt;&lt;p&gt;The Department of Biomedical Engineering a
 t the University of Alberta is a joint effort between the Faculty of Engin
 eering and the Faculty of Medicine and Dentistry. The University is also t
 he host site for the National Research Council&amp;rsquo\;s National Institute
  of Nanotechnology. Together these entities create a critical mass for res
 earch in nanomedicine.&lt;/p&gt;\n&lt;p&gt;&amp;nbsp\;&lt;br /&gt;Nanomedicine involves drug del
 ivery using nanopolymers and aerosols to promote bone and tissue regenerat
 ion and the development of improved diagnostic tools including MEMS and NE
 MS. Wound healing and disease diagnosis are areas of active research.&amp;nbsp
 \;&lt;/p&gt;\n&lt;p&gt;&lt;br /&gt;Silver\, and specifically silver ions Ag+\, are known to 
 be beneficial in the treatment of wounds. In the mid 1990s\, nanotechnolog
 y&amp;nbsp\; provided an opportunity to develop a new silver delivery system t
 hat released biologically active species other than Ag+. Nanocrystalline s
 ilver releases multiple species species into solution which have different
  biological properties than Ag+. In vitro\, in vivo and clinical studies h
 ave clearly demonstrated that this new form of silver has unique anti-infl
 ammatory and anti microbial properties.&lt;br /&gt;&lt;br /&gt;Nanotechnology can not 
 only change the chemical properties of a material but also its optical pro
 perties. Current work using these modified optical properties is aimed at 
 point of care diagnostics which require no amplification and can be read b
 y eye. Such developments would make it possible to see molecules as small 
 as 2nm on a surface.&lt;br /&gt;&lt;br /&gt;The speaker will discuss the use of nanote
 chnology in the treatment of current medical problems.&lt;/p&gt;\n&lt;p&gt;&amp;nbsp\;&lt;/p&gt;
 \n&lt;p&gt;&lt;strong&gt;Speaker &amp;nbsp\; &amp;nbsp\; &amp;nbsp\; &amp;nbsp\;&lt;/strong&gt;Dr&lt;strong&gt;&amp;nb
 sp\;&lt;/strong&gt;Robert E. Burrell\, AOE\, CSM\, PhD\, FCAHS\, FNAIDr.&amp;nbsp\;&lt;
 /p&gt;\n&lt;p&gt;&amp;nbsp\;&lt;/p&gt;\n&lt;p&gt;Dr Burrell\, is the Sorensen Chair in Commercializ
 ation of Biomedical Technology and a Professor of Chemical and Materials E
 ngineering in the Faculty of Engineering as well as Professor and Chair of
  Biomedical Engineering in the Faculties of Engineering and Medicine &amp;amp\
 ; Dentistry at the University of Alberta.&amp;nbsp\;&amp;nbsp\;He is a former two 
 term Canada Research Chair in Nanostructured Biomaterials. He has been rec
 ognized worldwide for his work in wound care. He is a named inventor on &amp;g
 t\;300 patents and patent applications worldwide including those for Actic
 oat dressings\, the world&amp;rsquo\;s first therapeutic application of nanote
 chnology. In Canada\, he has won the two highest awards for Innovation &amp;nd
 ash\; the Governor General&amp;rsquo\;s Innovation Award and Principal Award f
 rom the Manning Foundation. He has also received the Meritorious Service C
 ross\, is a fellow of The Canadian Academy of Health Sciences and has won 
 the Jonas Salk Award\, the ASM International - ASM Engineering Materials A
 chievement Award\,&amp;nbsp\;World Union of Wound Healing Society Lifetime Ach
 ievement Award\, Fellow of the National Academy of Inventors and a member 
 of the Alberta Order of Excellence.&lt;/p&gt;
END:VEVENT
END:VCALENDAR

